Select [acty]
Optimal [qlco]
antiplatelet therapy [topp]
Patients [podg]
coronary heart disease [dsyn]
CYP2C19 [aapp, enzy]
Polymorphism [genf]
Estimate [qnco]
Optimal [qlco]
antiplatelet therapy [topp]
Select [acty]
CYP2C19 [aapp, enzy]
Polymorphism [genf]
Subject [grup]
Methods [inpr]
prospective [resa]
randomized [resa]
Trial [resa]
included [ftcn]
Patients [podg]
Men [popg]
Women [popg]
PER [gngm]
Cutaneous [spco]
coronary [bpoc]
intervention [hlca]
Initially [tmco]
Received [qlco]
Dual [inpr]
antiplatelet therapy [topp]
clopidogrel [orch, phsu]
mg/mg [qnco]
Acetylsalicylic Acid [orch, phsu]
Genetic Testing [lbpr]
Performed [ftcn]
Patients [podg]
Allele [gngm]
variants [qlco]
Genes [gngm]
Cytochrome P-450 [aapp, enzy]
Isoenzymes [aapp, enzy]
Efficiency [qnco]
antiplatelet therapy [topp]
Evaluated [ftcn]
carriers [fndg]
Allele [gngm]
CYP2C19 [aapp, enzy]
randomized [resa]
subgroups [virs]
antiplatelet therapy [topp]
therapy [ftcn]
Changed [ftcn]
subgroup [virs]
Dose [qnco]
clopidogrel [orch, phsu]
Increased [qnco]
mg day [qnco]
Acetylsalicylic Acid [orch, phsu]
Unchanged [fndg]
subgroup [virs]
subgroup [virs]
therapy [ftcn]
Completely [qlco]
Changed [ftcn]
Regimen [topp]
Acetylsalicylic Acid [orch, phsu]
mg/mg [qnco]
Ticagrelor [nnon, phsu]
>90 [qnco]
Twice daily [tmco]
days [tmco]
Platelet aggregation [celf]
subgroups [virs]
Investigation [hlca]
CYP2C19 [aapp, enzy]
Alleles [gngm]
Comparison [acty]
baseline [bodm]
Platelet aggregation [celf]
Levels [qlco]
Same [qlco]
Platelet [cell]
therapy [ftcn]
statistically significant [qnco]
carriers [fndg]
carriers [fndg]
P NOS [aapp, imft]
Compared [acty]
baseline [bodm]
Values [qlco]
Drug Therapy [topp]
Switch [mnob]
Induced [ftcn]
reduction [npop]
Platelet aggregation [celf]
subgroups [virs]
P NOS [aapp, imft]
P NOS [aapp, imft]
statistically significant [qnco]
subgroups [virs]
determination [lbpr]
CYP2C19 gene [gngm]
Polymorphism [genf]
Personalized [qlco]
Approach [spco]
Applied [hlca]
antiplatelet therapy [topp]
Patients [podg]
coronary artery disease [dsyn]
